Putative suppressing effect of IgG Fc-conjugated haemagglutinin (HA) stalk of influenza virus H7N9 on the neutralizing immunogenicity of Fc-conjugated HA head: implication for rational design of HA-based influenza vaccines

被引:7
作者
He, B. [1 ]
Xia, S. [1 ]
Yu, F. [1 ]
Fu, Y. [1 ]
Li, W. [1 ]
Wang, Q. [1 ]
Lu, L. [1 ]
Jiang, S. [1 ,2 ,3 ]
机构
[1] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China
[3] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA
关键词
RECEPTOR-BINDING DOMAIN; RESPIRATORY SYNDROME CORONAVIRUS; MUCOSAL IMMUNE-RESPONSES; SPIKE PROTEIN; SARS-COV; INTRANASAL VACCINATION; H5N1; INFLUENZA; ANTIBODIES; PROTECTION; TARGET;
D O I
10.1099/jgv.0.000365
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The emergence of influenza A H7N9 in infection has posed a great threat to public health globally. Poor immunogenicity of H7N9 haemagglutinin (HA) is a major obstacle to the development of an effective H7N9 vaccine. Here, we found that the vaccine containing the H7HA head conjugated with IgG Fc (Hd-Fc) induced strong neutralizing antibody responses and protection against H7N9 infection, whilst the Fc-conjugated H7HA stalk (St-Fc)-based vaccine could not induce neutralizing antibodies, although the St-Fc-immunized mice were partially protected. The vaccines containing the full-length extracellular domain of HA conjugated with Fc and the mixture of Hd-Fc plus St-Fc induced significantly lower neutralizing antibody and haemagglutination inhibition titres than the Hd-Fc-based vaccine. These results suggest that the St-Fc may have inhibitory effects on the neutralizing immunogenicity of Hd-Fc. Therefore, the neutralizing domain(s), such as the receptor-binding domain, in the HA head should be kept and the non-neutralizing domain(s) in the HA stalk with the ability to potentially suppress the neutralizing immunogenicity of HA head should be removed from Fc-conjugated HA-based influenza vaccines to increase the neutralizing antibody response.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 28 条
[1]   A Cell Culture-Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults [J].
Bart, Stephan A. ;
Hohenboken, Matthew ;
Della Cioppa, Giovanni ;
Narasimhan, Vas ;
Dormitzer, Philip R. ;
Kanesa-thasan, Niranjan .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (234)
[2]   Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge [J].
Bommakanti, Gayathri ;
Citron, Michael P. ;
Hepler, Robert W. ;
Callahan, Cheryl ;
Heidecker, Gwendolyn J. ;
Najar, Tariq Ahmad ;
Lu, Xianghan ;
Joyce, Joseph G. ;
Shiver, John W. ;
Casimiro, Danilo R. ;
ter Meulen, Jan ;
Liang, Xiaoping ;
Varadarajan, Raghavan .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (31) :13701-13706
[3]   The structural biology of type I viral membrane fusion [J].
Colman, PM ;
Lawrence, MC .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (04) :309-319
[4]   Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection [J].
Du, Lanying ;
Zhao, Guangyu ;
Lin, Yongping ;
Sui, Hongyan ;
Chan, Chris ;
Ma, Selene ;
He, Yuxian ;
Jiang, Shibo ;
Wu, Changyou ;
Yuen, Kwok-Yung ;
Jin, Dong-Yan ;
Zhou, Yusen ;
Zheng, Bo-Jian .
JOURNAL OF IMMUNOLOGY, 2008, 180 (02) :948-956
[5]   Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model [J].
Du, Lanying ;
Zhao, Guangyu ;
He, Yuxian ;
Guo, Yan ;
Zheng, Bo-Jian ;
Jiang, Shibo ;
Zhou, Yusen .
VACCINE, 2007, 25 (15) :2832-2838
[6]   A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines [J].
Du, Lanying ;
Kou, Zhihua ;
Ma, Cuiqing ;
Tao, Xinrong ;
Wang, Lili ;
Zhao, Guangyu ;
Chen, Yaoqing ;
Yu, Fei ;
Tseng, Chien-Te K. ;
Zhou, Yusen ;
Jiang, Shibo .
PLOS ONE, 2013, 8 (12)
[7]   Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development [J].
Du, Lanying ;
Zhao, Guangyu ;
Kou, Zhihua ;
Ma, Cuiqing ;
Sun, Shihui ;
Poon, Vincent K. M. ;
Lu, Lu ;
Wang, Lili ;
Debnath, Asim K. ;
Zheng, Bo-Jian ;
Zhou, Yusen ;
Jiang, Shibo .
JOURNAL OF VIROLOGY, 2013, 87 (17) :9939-9942
[8]   A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection [J].
Du, Lanying ;
Zhao, Guangyu ;
Sun, Shihui ;
Zhang, Xiujuan ;
Zhou, Xiaojun ;
Guo, Yan ;
Li, Ye ;
Zhou, Yusen ;
Jiang, Shibo .
PLOS ONE, 2013, 8 (01)
[9]   Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies [J].
Du, Lanying ;
Zhao, Guangyu ;
Zhang, Xiujuan ;
Liu, Zhonghua ;
Yu, Hong ;
Zheng, Bo-Jian ;
Zhou, Yusen ;
Jiang, Shibo .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) :580-585
[10]   The spike protein of SARS-CoV - a target for vaccine and therapeutic development [J].
Du, Lanying ;
He, Yuxian ;
Zhou, Yusen ;
Liu, Shuwen ;
Zheng, Bo-Jian ;
Jiang, Shibo .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (03) :226-236